Published in Proc Natl Acad Sci U S A on September 15, 2009
An extracellular interactome of immunoglobulin and LRR proteins reveals receptor-ligand networks. Cell (2013) 2.36
High-resolution transcriptome of human macrophages. PLoS One (2012) 1.42
Human SRMAtlas: A Resource of Targeted Assays to Quantify the Complete Human Proteome. Cell (2016) 1.32
PSGL-1/selectin and ICAM-1/CD18 interactions are involved in macrophage-induced drug resistance in myeloma. Leukemia (2012) 1.15
COLT-Cancer: functional genetic screening resource for essential genes in human cancer cell lines. Nucleic Acids Res (2011) 1.08
A mass spectrometric-derived cell surface protein atlas. PLoS One (2015) 1.04
Translational analysis of mouse and human placental protein and mRNA reveals distinct molecular pathologies in human preeclampsia. Mol Cell Proteomics (2011) 0.92
miRIAD-integrating microRNA inter- and intragenic data. Database (Oxford) (2014) 0.91
Insights into gliomagenesis: systems biology unravels key pathways. Genome Med (2009) 0.90
Mutational analysis of genes coding for cell surface proteins in colorectal cancer cell lines reveal novel altered pathways, druggable mutations and mutated epitopes for targeted therapy. Oncotarget (2014) 0.90
The pancreatic beta cell surface proteome. Diabetologia (2012) 0.85
Characterizing the human hematopoietic CDome. Front Genet (2014) 0.84
SurfaceomeDB: a cancer-orientated database for genes encoding cell surface proteins. Cancer Immun (2012) 0.80
Differential proteomic analysis of pathway biomarkers in human breast cancer by integrated bioinformatics. Oncol Lett (2012) 0.80
Surgically resected human tumors reveal the biological significance of the gastric cancer stem cell markers CD44 and CD26. Oncol Lett (2015) 0.80
A Combined Omics Approach to Generate the Surface Atlas of Human Naive CD4+ T Cells during Early T-Cell Receptor Activation. Mol Cell Proteomics (2015) 0.79
The human cell surfaceome of breast tumors. Biomed Res Int (2013) 0.79
Alternative polyadenylation allows differential negative feedback of human miRNA miR-579 on its host gene ZFR. PLoS One (2015) 0.78
Proline rich motifs as drug targets in immune mediated disorders. Int J Pept (2012) 0.78
Cell surface profiling using high-throughput flow cytometry: a platform for biomarker discovery and analysis of cellular heterogeneity. PLoS One (2014) 0.78
Exploring the surfaceome of Ewing sarcoma identifies a new and unique therapeutic target. Proc Natl Acad Sci U S A (2016) 0.78
Functional analysis of human cancer-associated genes and their association with the testes and epididymis. Oncol Lett (2013) 0.77
Evolutionarily conserved intercalated disc protein Tmem65 regulates cardiac conduction and connexin 43 function. Nat Commun (2015) 0.76
Bioinformatics Analysis of the Human Surfaceome Reveals New Targets for a Variety of Tumor Types. Int J Genomics (2016) 0.75
N-glycoprotein surfaceome of human induced pluripotent stem cell derived hepatic endoderm. Proteomics (2016) 0.75
Oncogenic processes. Biomed Res Int (2014) 0.75
Molecular computing: in situ computation of cell identity. Nat Nanotechnol (2013) 0.75
Improved plasma membrane proteome coverage with a label-free non-affinity-purified workflow. Proteomics (2017) 0.75
Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature (2008) 75.40
Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. J Mol Biol (2001) 66.87
The genomic landscapes of human breast and colorectal cancers. Science (2007) 38.12
The Pfam protein families database. Nucleic Acids Res (2007) 30.53
Inflammation and cancer: back to Virchow? Lancet (2001) 27.40
Genes expressed in human tumor endothelium. Science (2000) 10.75
Cancer/testis antigens, gametogenesis and cancer. Nat Rev Cancer (2005) 9.46
Activating Smoothened mutations in sporadic basal-cell carcinoma. Nature (1998) 7.43
An anatomy of normal and malignant gene expression. Proc Natl Acad Sci U S A (2002) 4.45
Requirement of tumor necrosis factor receptor-associated factor (TRAF)6 in interleukin 17 signal transduction. J Exp Med (2000) 3.14
The gene expression signatures of melanoma progression. Proc Natl Acad Sci U S A (2005) 3.05
The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment. Genome Res (2003) 2.91
TACE cleavage of proamphiregulin regulates GPCR-induced proliferation and motility of cancer cells. EMBO J (2003) 2.55
NY-ESO-1: review of an immunogenic tumor antigen. Adv Cancer Res (2006) 2.44
An atlas of human gene expression from massively parallel signature sequencing (MPSS). Genome Res (2005) 2.39
Detection and evaluation of intron retention events in the human transcriptome. RNA (2004) 2.18
LST-2, a human liver-specific organic anion transporter, determines methotrexate sensitivity in gastrointestinal cancers. Gastroenterology (2001) 2.02
Effect of SLCO1B3 haplotype on testosterone transport and clinical outcome in caucasian patients with androgen-independent prostatic cancer. Clin Cancer Res (2008) 1.95
Identification of endosialin, a cell surface glycoprotein of vascular endothelial cells in human cancer. Proc Natl Acad Sci U S A (1992) 1.62
Patched1 functions as a gatekeeper by promoting cell cycle progression. Cancer Res (2006) 1.56
Growth inhibition and radiosensitization of glioblastoma and lung cancer cells by small interfering RNA silencing of tumor necrosis factor receptor-associated factor 2. Cancer Res (2008) 1.55
Inhibition of smoothened signaling prevents ultraviolet B-induced basal cell carcinomas through regulation of Fas expression and apoptosis. Cancer Res (2004) 1.50
A monoclonal cytolytic T-lymphocyte response observed in a melanoma patient vaccinated with a tumor-specific antigenic peptide encoded by gene MAGE-3. Proc Natl Acad Sci U S A (2001) 1.49
A bicistronic CYCLIN D1-TROP2 mRNA chimera demonstrates a novel oncogenic mechanism in human cancer. Cancer Res (2008) 1.49
Identification of Trop-2 as an oncogene and an attractive therapeutic target in colon cancers. Mol Cancer Ther (2008) 1.41
The A3 adenosine receptor is highly expressed in tumor versus normal cells: potential target for tumor growth inhibition. Clin Cancer Res (2004) 1.36
Genome-scale identification of membrane-associated human mRNAs. PLoS Genet (2006) 1.31
Endosialin (CD248) is a marker of tumor-associated pericytes in high-grade glioma. Mod Pathol (2008) 1.26
Sense-antisense pairs in mammals: functional and evolutionary considerations. Genome Biol (2007) 1.26
Immunogenetics of human cell surface differentiation. Annu Rev Immunol (1989) 1.25
Serum levels of leptin and proinflammatory cytokines in patients with advanced-stage cancer at different sites. J Mol Med (Berl) (2000) 1.18
Sonic hedgehog inversely regulates the expression of angiopoietin-1 and angiopoietin-2 in fibroblasts. Int J Mol Med (2007) 1.16
Differential use of signal peptides and membrane domains is a common occurrence in the protein output of transcriptional units. PLoS Genet (2006) 1.12
Immunomic analysis of human sarcoma. Proc Natl Acad Sci U S A (2003) 1.11
Human liver-specific organic anion transporter-2 is a potent prognostic factor for human breast carcinoma. Cancer Sci (2007) 1.11
Insulin-like growth factor 1 stimulates KCl cotransport, which is necessary for invasion and proliferation of cervical cancer and ovarian cancer cells. J Biol Chem (2004) 1.01
Identification of the gonad-specific anion transporter SLCO6A1 as a cancer/testis (CT) antigen expressed in human lung cancer. Cancer Immun (2004) 1.00
Glycoprotein A34, a novel target for antibody-based cancer immunotherapy. Cancer Immun (2006) 0.91
Interferon-gamma regulation of TNFalpha-induced matrix metalloproteinase 3 expression and migration of human glioma T98G cells. Int J Cancer (2007) 0.86
TRAF-mediated TNFR-family signaling. Curr Protoc Immunol (2002) 0.84
Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. Science (2011) 15.79
Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol (2002) 14.75
Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. Proc Natl Acad Sci U S A (2005) 10.89
The genome sequence of the plant pathogen Xylella fastidiosa. The Xylella fastidiosa Consortium of the Organization for Nucleotide Sequencing and Analysis. Nature (2000) 10.03
Cancer/testis antigens, gametogenesis and cancer. Nat Rev Cancer (2005) 9.46
The immunobiology of cancer immunosurveillance and immunoediting. Immunity (2004) 9.39
Comparison of the genomes of two Xanthomonas pathogens with differing host specificities. Nature (2002) 8.42
The three Es of cancer immunoediting. Annu Rev Immunol (2004) 8.20
Adaptive immunity maintains occult cancer in an equilibrium state. Nature (2007) 8.14
Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting. Nature (2012) 7.76
A role for CD95 ligand in preventing graft rejection. Nature (1995) 6.07
Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study. JAMA (2001) 5.52
Involvement of the V1/V2 variable loop structure in the exposure of human immunodeficiency virus type 1 gp120 epitopes induced by receptor binding. J Virol (1995) 5.43
Antibody therapy of cancer. Nat Rev Cancer (2012) 5.17
Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer. J Clin Oncol (1996) 4.99
The cancer/testis genes: review, standardization, and commentary. Cancer Immun (2004) 4.78
Cancer/testis antigens: an expanding family of targets for cancer immunotherapy. Immunol Rev (2002) 4.63
TET1, a member of a novel protein family, is fused to MLL in acute myeloid leukemia containing the t(10;11)(q22;q23). Leukemia (2003) 4.17
Rapid silver staining and recovery of PCR products separated on polyacrylamide gels. Biotechniques (1994) 4.00
CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit. Proc Natl Acad Sci U S A (2008) 3.80
CD4-Induced conformational changes in the human immunodeficiency virus type 1 gp120 glycoprotein: consequences for virus entry and neutralization. J Virol (1998) 3.60
Research needs for the risk assessment of health and environmental effects of endocrine disruptors: a report of the U.S. EPA-sponsored workshop. Environ Health Perspect (1996) 3.34
Effectiveness of routine ultrasonography in detecting fetal structural abnormalities in a low risk population. BMJ (1991) 3.30
The roles of IFN gamma in protection against tumor development and cancer immunoediting. Cytokine Growth Factor Rev (2002) 3.28
Human IgE, IgG4 and resistance to reinfection with Schistosoma haematobium. Nature (1991) 3.18
Tumor-infiltrating NY-ESO-1-specific CD8+ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer. Proc Natl Acad Sci U S A (2010) 3.12
"MIATA"-minimal information about T cell assays. Immunity (2009) 2.90
Integrated NY-ESO-1 antibody and CD8+ T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab. Proc Natl Acad Sci U S A (2011) 2.90
Preoperative characterisation of clear-cell renal carcinoma using iodine-124-labelled antibody chimeric G250 (124I-cG250) and PET in patients with renal masses: a phase I trial. Lancet Oncol (2007) 2.83
Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4(+) and CD8(+) T cell responses in humans. Proc Natl Acad Sci U S A (2004) 2.80
Direct detection of HIV RNA expression in seropositive subjects. Lancet (1988) 2.75
A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer. Clin Cancer Res (2003) 2.73
Cancer-testis genes are coordinately expressed and are markers of poor outcome in non-small cell lung cancer. Clin Cancer Res (2005) 2.73
The contribution of 700,000 ORF sequence tags to the definition of the human transcriptome. Proc Natl Acad Sci U S A (2001) 2.71
Associations between gene expressions in breast cancer and patient survival. Hum Genet (2002) 2.67
Genome-wide analysis of cancer/testis gene expression. Proc Natl Acad Sci U S A (2008) 2.66
Infectious complications of subcutaneous interleukin-2 and interferon-alpha. Lancet (1992) 2.65
Vaccination with an NY-ESO-1 peptide of HLA class I/II specificities induces integrated humoral and T cell responses in ovarian cancer. Proc Natl Acad Sci U S A (2007) 2.61
NY-ESO-1 and LAGE-1 cancer-testis antigens are potential targets for immunotherapy in epithelial ovarian cancer. Cancer Res (2003) 2.53
NY-ESO-1: review of an immunogenic tumor antigen. Adv Cancer Res (2006) 2.44
Molecular diagnosis of infective endocarditis--a new Duke's criterion. Scand J Infect Dis (2001) 2.36
Defining the critical hurdles in cancer immunotherapy. J Transl Med (2011) 2.32
Current status of ketamine anaesthesia. Lancet (1971) 2.28
Which gp160 vaccine? Nature (1993) 2.27
A new method for radionuclide imaging of myocardial infarcts. Radiology (1974) 2.24
Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. Proc Natl Acad Sci U S A (2000) 2.21
Vaccination with NY-ESO-1 protein and CpG in Montanide induces integrated antibody/Th1 responses and CD8 T cells through cross-priming. Proc Natl Acad Sci U S A (2007) 2.19
Recombinant vaccinia/fowlpox NY-ESO-1 vaccines induce both humoral and cellular NY-ESO-1-specific immune responses in cancer patients. Proc Natl Acad Sci U S A (2006) 2.19
CTdatabase: a knowledge-base of high-throughput and curated data on cancer-testis antigens. Nucleic Acids Res (2008) 2.14
Certification, accreditation, and quality control in behavior analysis. Behav Anal (2001) 2.14
Origin of genes. Proc Natl Acad Sci U S A (1997) 2.12
CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma. Proc Natl Acad Sci U S A (2007) 2.11
Survey of naturally occurring CD4+ T cell responses against NY-ESO-1 in cancer patients: correlation with antibody responses. Proc Natl Acad Sci U S A (2003) 2.09
Lumbosacral cerebrospinal fluid volume is the primary determinant of sensory block extent and duration during spinal anesthesia. Anesthesiology (1998) 2.09
Oxybenzone oxidation following solar irradiation of skin: photoprotection versus antioxidant inactivation. J Invest Dermatol (1996) 2.07
Laryngeal mask airway for caesarean section. Anaesthesia (1990) 2.05
Human chromosome 12 is required for elevated HIV-1 expression in human-hamster hybrid cells. Science (1989) 2.03
(124)I-huA33 antibody PET of colorectal cancer. J Nucl Med (2011) 2.01
Some historical and conceptual relations among logical positivism, operationism, and behaviorism. Behav Anal (1985) 1.99
CD8+ Foxp3+ regulatory T cells mediate immunosuppression in prostate cancer. Clin Cancer Res (2007) 1.94
Genealogical evidence for positive selection in the nef gene of HIV-1. Genetics (1999) 1.93
Relationship between "proto-splice sites" and intron phases: evidence from dicodon analysis. Proc Natl Acad Sci U S A (1998) 1.90
A comparison of chloramphenicol, trimethoprim-sulfamethoxazole, and doxycycline with doxycycline alone as maintenance therapy for melioidosis. Clin Infect Dis (1999) 1.89
Pumilio is essential for function but not for distribution of the Drosophila abdominal determinant Nanos. Genes Dev (1992) 1.85
Identification of human chromosome 22 transcribed sequences with ORF expressed sequence tags. Proc Natl Acad Sci U S A (2000) 1.84
The cancer-testis antigens CT7 (MAGE-C1) and MAGE-A3/6 are commonly expressed in multiple myeloma and correlate with plasma-cell proliferation. Blood (2005) 1.84
Preclinical evaluation of MORAb-003, a humanized monoclonal antibody antagonizing folate receptor-alpha. Cancer Immun (2007) 1.82
Head-upright tilt-table testing in evaluation and management of the malignant vasovagal syndrome. Am J Cardiol (1992) 1.82
Phase II study of weekly intravenous trastuzumab (Herceptin) in patients with HER2/neu-overexpressing metastatic breast cancer. Semin Oncol (1999) 1.82
Evaluation of the effect of diagnostic methodology on the reported incidence of ventilator-associated pneumonia. Thorax (2009) 1.81
A phase I clinical trial with monoclonal antibody ch806 targeting transitional state and mutant epidermal growth factor receptors. Proc Natl Acad Sci U S A (2007) 1.79
Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia. J Gen Virol (2000) 1.78
Transferable anticancer innate immunity in spontaneous regression/complete resistance mice. Proc Natl Acad Sci U S A (2006) 1.77
Collagen XVIII, containing an endogenous inhibitor of angiogenesis and tumor growth, plays a critical role in the maintenance of retinal structure and in neural tube closure (Knobloch syndrome). Hum Mol Genet (2000) 1.76
IFN unresponsiveness in LNCaP cells due to the lack of JAK1 gene expression. Cancer Res (2005) 1.75
Impaired growth and fertility of cAMP-specific phosphodiesterase PDE4D-deficient mice. Proc Natl Acad Sci U S A (1999) 1.73
Appearance of specific colostrum antibodies after clinical infection with Salmonella typhimurium. Br Med J (1974) 1.73
Evolution of the intron-exon structure of eukaryotic genes. Curr Opin Genet Dev (1995) 1.72
Stimulation of hepatic regeneration after partial hepatectomy by infusion of a cytosol extract from regenerating dog liver. Surg Gynecol Obstet (1980) 1.72
Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-STO 22, to assess quality of life in patients with gastric cancer. Eur J Cancer (2004) 1.70
A d.c. magnetic metamaterial. Nat Mater (2008) 1.69
Farletuzumab, a humanized monoclonal antibody against folate receptor alpha, in epithelial ovarian cancer: a phase I study. Clin Cancer Res (2010) 1.67
Characterization of potential endocrine-related health effects at low-dose levels of exposure to PCBs. Environ Health Perspect (1999) 1.66
Evaluation of midazolam as an intravenous induction agent. Anaesthesia (1981) 1.64
Health services use by urban women with or at risk for HIV-1 infection: the HIV Epidemiology Research Study (HERS). J Acquir Immune Defic Syndr Hum Retrovirol (1998) 1.61
General practitioners' and patients' models of obesity: whose problem is it? Patient Educ Couns (2001) 1.59
In vivo and in vitro evidence for hydrogen peroxide (H2O2) accumulation in the epidermis of patients with vitiligo and its successful removal by a UVB-activated pseudocatalase. J Investig Dermatol Symp Proc (1999) 1.58
Characterization of the ets oncogene family member, fli-1. J Biol Chem (1993) 1.57
Subsistence strategies of two "savanna" chimpanzee populations: the stable isotope evidence. Am J Primatol (1999) 1.57
A monoclonal antibody recognizing human cancers with amplification/overexpression of the human epidermal growth factor receptor. Proc Natl Acad Sci U S A (2003) 1.56
A chink in HIV's armour? Nature (1990) 1.56
Evaluation of a point-of-care blood test for identification of Ebola virus disease at Ebola holding units, Western Area, Sierra Leone, January to February 2015. Euro Surveill (2015) 1.56
Ketamine as an induction agent in anaesthetics. Lancet (1970) 1.55